Thursday, October 15, 2009
FDA Panel Likes Acorda's Multiple Sclerosis Drug - Wall Street Journal (blog)
FDA Panel Likes Acorda's Multiple Sclerosis Drug
Wall Street Journal (blog)
Shares of Acorda Therapeutics, a small company that's developing the drug, rose more than 40% in after-hours trading. As often happens when a small ...
and more »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment